Philadelphia Trust CO Eli Lilly & CO Transaction History

Philadelphia Trust CO

$1.38 Billion
Q3 2024

A detailed history of Philadelphia Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Philadelphia Trust CO holds 4,274 shares of LLY stock, worth $3.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

4,274

Previous 4,254 0.47%

Holding current value

$3.4 Million

Previous $3.85 Million 1.66%

% of portfolio

0.27%

Previous 0.3%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $15,442 - $19,200	20 Added 0.47%	4,274 $3.79 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $7,248 - $9,090	10 Added 0.24%	4,254 $3.85 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $11,844 - $15,845	-20 Reduced 0.47%	4,244 $3.3 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $17,856 - $21,050	34 Added 0.8%	4,264 $2.49 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $2,173 - $2,996	5 Added 0.12%	4,230 $2.27 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $110,483 - $147,728	-315 Reduced 6.94%	4,225 $1.98 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $67,525 - $78,680	-210 Reduced 4.42%	4,540 $1.66 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $29,648 - $33,787	100 Added 2.15%	4,750 $1.54 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $284,304 - $333,815	-1,020 Reduced 17.99%	4,650 $1.51 Million
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $4,693 - $5,833	20 Added 0.35%	5,670 $1.62 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $112,425 - $139,520	-500 Reduced 8.13%	5,650 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $282,540 - $347,705	-1,275 Reduced 17.17%	6,150 $1.42 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $16,432 - $21,272	100 Added 1.37%	7,425 $1.39 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $9,784 - $12,947	-75 Reduced 1.01%	7,325 $1.24 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $26,786 - $33,153	-225 Reduced 2.95%	7,400 $1.03 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $128,304 - $158,916	-1,200 Reduced 13.6%	7,625 $1 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $117,575 - $127,892	-1,101 Reduced 11.09%	8,825 $987,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $27,697 - $32,330	-250 Reduced 2.46%	9,926 $1.1 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $35,619 - $41,926	320 Added 3.25%	10,176 $1.32 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $10,590 - $11,864	100 Added 1.03%	9,856 $1.14 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $16,326 - $19,272	-220 Reduced 2.21%	9,756 $755,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $10,242 - $10,986	125 Added 1.27%	9,976 $843,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $759,216 - $842,654	9,851	9,851 $843,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account

Philadelphia Trust CO Eli Lilly & CO Transaction History